Fate Therapeutics, Inc. (FATE) NASDAQ
1.17
-0.005(-0.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.17
-0.005(-0.43%)
Currency In USD
| Market Cap | 116.72M |
| Enterprise Value | 147.94M |
| P/E Ratio | -1.02 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 20.47 |
| Price/Book Ratio | 0.67 |
| Enterprise/Revenue | 25.17 |
| Enterprise/EBITDA | -1.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -20.51 |
| Operating Margin | -22.22 |
| Return On Assets | -0.43 |
| Return On Equity | -0.55 |
| Revenue | 6.65M |
| Revenue/Share | 0.06 |
| Gross Profit | -6.26M |
| EBITDA | -127.02M |
| Net Income | -136.32M |
| Diluted EPS | -1.15 |
| Total Cash | 203.66M |
| Total Cash/Share | 1.71 |
| Total Debt | 77.85M |
| Total Debt/Equity | 0.38 |
| Current Ratio | 5.79 |
| Book Value Per Share | 1.74 |
| 52-Week Change | 24.01 |
| 52-Week High | 1.94 |
| 52-Week Low | 0.66 |
| Moving Average 50 Days | 1.23 |
| Moving Average 200 Days | 1.18 |
| Average Volume | 1.67M |
| Shares Outstanding | 116.26M |
| % Held by Institutions | 60.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |